2m 2m 2m 2m 2m 2m 2m
SURROZEN (SRZN)
NASDAQ
$23.96-$0.03 (-0.13%)
Price as of Aug 21, 2026 7:30 PM EDT- $282.0MMarket Cap
- 108.79%1-Year Change
- BiotechnologyIndustry
SURROZEN (SRZN)
$23.96-$0.03 (-0.13%)
SRZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.99 | ||
Change | +$0.49 (+2.09%) | ||
Open | $23.73 | ||
High | $25.01 | ||
Low | $23.49 | ||
Previous Close | $23.50 | ||
Volume | 149,722 | ||
30-Day Average Volume | 271,984 | ||
1-Week Change | 0.13% | ||
1-Month Change | 4.35% | ||
1-Year Change | 108.79% | ||
3-Year Change | 171.07% | ||
5-Year Change | -78.90% | ||
Fundamentals | |||
Shares Outstanding | 11.8M | ||
Total Assets | $115.6M | ||
Market Cap | $282.0M | ||
Enterprise Value | $179.9M | ||
Period: QTR TTM FY | |||
Revenue | $5.0M | ||
Net Income | $50.2M | ||
Free Cash Flow | -$7.4M | ||
EBIT | $50.2M | ||
EBITDA | $50.2M | ||
Net Working Capital | $100.4M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | 36 | ||
P/B | -1 | ||
P/E | -59 | ||
PEG | -1 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/14/2023 | ||
Earnings & Revenue